5 hasil untuk "Jun Peng Lin"
Menampilkan 1–5 · 0,32 detik · RSS
-
Artikel Jurnal
The role of neoadjuvant therapy in elderly patients with T1b-T2N + esophageal cancer: a population-based cohort study
Abstract Background Studies regarding whether elderly patients (≥ 70 years) with T1b-T2N + esophageal cancer (EC) could benefit from neoadjuvant therapy (NAT) are lacking. Therefore, the aim of this study was to investigate the impact of NAT on the outcomes of elderly patients with T1b-T2N + EC…
-
Artikel Jurnal
Prognosis and risk factors for pathological non-response to neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma
BackgroundNeoadjuvant chemotherapy combined with immunotherapy (NACI) is promising for treating locally advanced esophageal squamous cell carcinoma (LA-ESCC), yet a subset of patients exhibit a pathological non-response (pNR). The prognosis and risk factors for pNR to NACI remain unclear.MethodsWe…
-
Artikel Jurnal
Safety and Efficacy of Camrelizumab in Combination With Nab-Paclitaxel Plus S-1 for the Treatment of Gastric Cancer With Serosal Invasion
ObjectiveTo investigate the safety and efficacy of camrelizumab in combination with nab-paclitaxel plus S-1 for the treatment of gastric cancer with serosal invasion.MethodTwo hundred patients with gastric cancer with serosal invasion who received neoadjuvant therapy from January 2012 to December…
-
Artikel Jurnal
Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection
Abstract Background We sought to investigate the prognostic value of complete blood count (CBC)-based biomarkers for patients with resectable gastric cancer (GC). Methods Patients with GC who underwent primary surgical resection between December 2008 and December 2013 were included. The estimated…
-
Artikel Jurnal
Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
Abstract Background The optimal treatment strategy for patients with borderline resectable (cT3br) esophageal squamous cell carcinoma (ESCC) remains unclear. Thus, the aim of this study was to compare the perioperative outcomes and prognoses between neoadjuvant chemotherapy combined with…